SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-009170
Filing Date
2023-04-04
Accepted
2023-04-04 07:03:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20230316_defa14a.htm DEFA14A 7780
2 pic1.jpg GRAPHIC 9640
3 pic2_page1.jpg GRAPHIC 233894
4 pic2_page2.jpg GRAPHIC 199580
  Complete submission text file 0001437749-23-009170.txt   619264
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 23795078
SIC: 2834 Pharmaceutical Preparations